Tulin Budak-Alpdogan

5PUBLICATIONS
32CO-AUTHORS
Haematological tumoursMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 26, 2026
Wired to Survive: How AML Cytogenetics Shape Apoptotic Dependence and Venetoclax Resistance.

|Jul 13, 2024
Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma Patients.

Omar S Al-Odat, Emily Nelson, Tulin Budak-Alpdogan

|Mar 29, 2023
Past, Present, and a Glance into the Future of Multiple Myeloma Treatment.

Weam Othman Elbezanti, Kishore B Challagundla, Subash C Jonnalagadda

|Jan 08, 2023
Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma.

Omar S Al-Odat, Daniel A Guirguis, Nicole K Schmalbach

|Nov 18, 2022
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.

Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet

Pageof 1

Frequent Collaborators

4 joint publications

Manoj K Pandey

3 joint publications

Subash C Jonnalagadda

1 joint publications

Naveen Pemmaraju

1 joint publications

Jayastu Senapati